Tchaikapharma High Quality Medicines AD (BUL:THQM)

Bulgaria · Delayed Price · Currency is BGN · Price in EUR

7.20

-0.15 (-2.04%)

At close: Aug 12, 2026

-12.04% (1Y)

Market Cap	1.40B -13.5%
Revenue (ttm)	69.28M +22.0%
Net Income	5.92M -5.9%
EPS	0.06 -4.4%
Shares Out	101.30M
PE Ratio	234.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	140
Open	6.05
Previous Close	7.35
Day's Range	6.05 - 7.20
52-Week Range	4.42 - 9.04
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About BUL:THQM

Tchaikapharma High Quality Medicines AD develops, manufactures, and sells medicines in Bulgaria. It offers anaesthesia, anti-inflammatory and anti-rheumatic, antibiotics, cardiovascular system, digestive system, diabetes and metabolism, nervous system, over-the-counter, respiratory system, oncology, and other medicines. The company was founded in 1999 and is headquartered in Sofia, Bulgaria. Tchaikapharma High Quality Medicines AD operates as a subsidiary of Commercial League Healthcare Group Inc. [Read more]

Industry Pharmaceutical Preparations

Founded 1999

Employees 214

Stock Exchange Bulgarian Stock Exchange

Ticker Symbol THQM

Full Company Profile

Financial Performance

In 2025, BUL:THQM's revenue was 32.74 million, an increase of 20.17% compared to the previous year's 27.24 million. Earnings were 3.08 million, an increase of 33.64%.

Financial numbers in EUR Financial Statements